Go Pro

National Research (NRC) Competitors

National Research logo
$21.83 +0.18 (+0.83%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$21.83 0.00 (0.00%)
As of 04:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NRC vs. NEO, HAWK, STGW, FIVN, and TIC

Should you buy National Research stock or one of its competitors? MarketBeat compares National Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Research include NeoGenomics (NEO), HawkEye 360 (HAWK), Stagwell (STGW), Five9 (FIVN), and TIC Solutions (TIC). These companies are all part of the "business services" industry.

How does National Research compare to NeoGenomics?

National Research (NASDAQ:NRC) and NeoGenomics (NASDAQ:NEO) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

National Research has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market. Comparatively, NeoGenomics has a beta of 1.74, indicating that its share price is 74% more volatile than the broader market.

National Research has a net margin of 6.52% compared to NeoGenomics' net margin of -13.30%. National Research's return on equity of 122.73% beat NeoGenomics' return on equity.

Company Net Margins Return on Equity Return on Assets
National Research6.52% 122.73% 14.18%
NeoGenomics -13.30%-2.80%-1.72%

National Research has higher earnings, but lower revenue than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$137.39M3.61$11.60M$0.3955.97
NeoGenomics$745.97M2.46-$108.03M-$0.77N/A

National Research presently has a consensus price target of $23.00, indicating a potential upside of 5.36%. NeoGenomics has a consensus price target of $13.86, indicating a potential downside of 1.79%. Given National Research's stronger consensus rating and higher probable upside, research analysts plainly believe National Research is more favorable than NeoGenomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
NeoGenomics
1 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.42

In the previous week, NeoGenomics had 5 more articles in the media than National Research. MarketBeat recorded 7 mentions for NeoGenomics and 2 mentions for National Research. National Research's average media sentiment score of 1.30 beat NeoGenomics' score of 0.70 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeoGenomics
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

47.3% of National Research shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 1.1% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

National Research beats NeoGenomics on 11 of the 16 factors compared between the two stocks.

How does National Research compare to HawkEye 360?

National Research (NASDAQ:NRC) and HawkEye 360 (NYSE:HAWK) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

National Research has higher earnings, but lower revenue than HawkEye 360.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$137.39M3.61$11.60M$0.3955.97
HawkEye 360$204.21M9.33N/AN/AN/A

National Research has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, HawkEye 360 has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

In the previous week, HawkEye 360 had 1 more articles in the media than National Research. MarketBeat recorded 3 mentions for HawkEye 360 and 2 mentions for National Research. National Research's average media sentiment score of 1.30 beat HawkEye 360's score of 0.40 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HawkEye 360
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

47.3% of National Research shares are held by institutional investors. Comparatively, 90.7% of HawkEye 360 shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 3.8% of HawkEye 360 shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

National Research currently has a consensus target price of $23.00, indicating a potential upside of 5.36%. HawkEye 360 has a consensus target price of $38.38, indicating a potential upside of 97.40%. Given HawkEye 360's stronger consensus rating and higher possible upside, analysts clearly believe HawkEye 360 is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
HawkEye 360
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89

National Research has a net margin of 6.52% compared to HawkEye 360's net margin of 0.00%. National Research's return on equity of 122.73% beat HawkEye 360's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research6.52% 122.73% 14.18%
HawkEye 360 N/A N/A N/A

Summary

HawkEye 360 beats National Research on 9 of the 15 factors compared between the two stocks.

How does National Research compare to Stagwell?

National Research (NASDAQ:NRC) and Stagwell (NASDAQ:STGW) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Stagwell had 4 more articles in the media than National Research. MarketBeat recorded 6 mentions for Stagwell and 2 mentions for National Research. National Research's average media sentiment score of 1.30 beat Stagwell's score of 1.05 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stagwell
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stagwell has higher revenue and earnings than National Research. National Research is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$137.39M3.61$11.60M$0.3955.97
Stagwell$2.91B0.67$29.10M$0.07112.43

National Research has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market. Comparatively, Stagwell has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

National Research has a net margin of 6.52% compared to Stagwell's net margin of 0.64%. National Research's return on equity of 122.73% beat Stagwell's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research6.52% 122.73% 14.18%
Stagwell 0.64%24.12%4.31%

National Research presently has a consensus price target of $23.00, indicating a potential upside of 5.36%. Stagwell has a consensus price target of $7.80, indicating a potential downside of 0.89%. Given National Research's stronger consensus rating and higher probable upside, analysts plainly believe National Research is more favorable than Stagwell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Stagwell
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

47.3% of National Research shares are held by institutional investors. Comparatively, 35.6% of Stagwell shares are held by institutional investors. 9.2% of National Research shares are held by company insiders. Comparatively, 11.2% of Stagwell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

National Research beats Stagwell on 9 of the 16 factors compared between the two stocks.

How does National Research compare to Five9?

Five9 (NASDAQ:FIVN) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Five9 has higher revenue and earnings than National Research. Five9 is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Five9$1.15B1.72$39.42M$0.6639.11
National Research$137.39M3.61$11.60M$0.3955.97

In the previous week, Five9 and Five9 both had 2 articles in the media. National Research's average media sentiment score of 1.30 beat Five9's score of 0.94 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Five9
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Research
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.6% of Five9 shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 1.2% of Five9 shares are owned by insiders. Comparatively, 9.2% of National Research shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Five9 currently has a consensus target price of $25.93, indicating a potential upside of 0.46%. National Research has a consensus target price of $23.00, indicating a potential upside of 5.36%. Given National Research's higher probable upside, analysts clearly believe National Research is more favorable than Five9.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Five9
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.61
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Five9 has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, National Research has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

National Research has a net margin of 6.52% compared to Five9's net margin of 4.87%. National Research's return on equity of 122.73% beat Five9's return on equity.

Company Net Margins Return on Equity Return on Assets
Five94.87% 12.66% 5.52%
National Research 6.52%122.73%14.18%

Summary

Five9 and National Research tied by winning 8 of the 16 factors compared between the two stocks.

How does National Research compare to TIC Solutions?

National Research (NASDAQ:NRC) and TIC Solutions (NYSE:TIC) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

47.3% of National Research shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 11.4% of TIC Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

National Research has a net margin of 6.52% compared to TIC Solutions' net margin of -5.77%. National Research's return on equity of 122.73% beat TIC Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
National Research6.52% 122.73% 14.18%
TIC Solutions -5.77%-3.82%-1.87%

National Research has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, TIC Solutions has a beta of 2.81, meaning that its stock price is 181% more volatile than the broader market.

National Research presently has a consensus price target of $23.00, suggesting a potential upside of 5.36%. TIC Solutions has a consensus price target of $11.50, suggesting a potential upside of 61.49%. Given TIC Solutions' higher possible upside, analysts clearly believe TIC Solutions is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
TIC Solutions
3 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.86

National Research has higher earnings, but lower revenue than TIC Solutions. TIC Solutions is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$137.39M3.61$11.60M$0.3955.97
TIC Solutions$1.53B1.03-$87.12M-$0.52N/A

In the previous week, TIC Solutions had 1 more articles in the media than National Research. MarketBeat recorded 3 mentions for TIC Solutions and 2 mentions for National Research. National Research's average media sentiment score of 1.30 beat TIC Solutions' score of 1.18 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TIC Solutions
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

National Research beats TIC Solutions on 10 of the 16 factors compared between the two stocks.

Get National Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRC vs. The Competition

MetricNational ResearchBUSINESS INFO SVC IndustryBusiness SectorNASDAQ Exchange
Market Cap$492.46M$17.55B$6.90B$12.61B
Dividend Yield2.96%1.87%3.12%8.00%
P/E Ratio55.9721.6728.6424.26
Price / Sales3.613.23344.87117.88
Price / Cash17.2213.9323.2149.36
Price / Book35.2114.745.706.29
Net Income$11.60M$644.38M$203.89M$330.66M
7 Day Performance-4.13%0.41%-1.59%-1.35%
1 Month Performance16.18%2.59%-2.23%-0.64%
1 Year Performance41.94%-22.43%13.25%19.08%

National Research Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRC
National Research
1.739 of 5 stars
$21.83
+0.8%
$23.00
+5.4%
+36.8%$492.46M$137.39M55.97490
NEO
NeoGenomics
1.628 of 5 stars
$14.50
-4.4%
$13.86
-4.4%
+94.4%$1.97B$745.97MN/A2,500
HAWK
HawkEye 360
3.8567 of 5 stars
$19.63
-1.7%
$38.38
+95.5%
N/A$1.92B$204.21MN/A403
STGW
Stagwell
2.5224 of 5 stars
$7.70
+1.6%
$7.80
+1.3%
+69.2%$1.88B$2.91B110.0012,629
FIVN
Five9
3.1608 of 5 stars
$24.99
+3.7%
$25.93
+3.8%
-3.0%$1.85B$1.15B37.862,910

Related Companies and Tools


This page (NASDAQ:NRC) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners